Literature DB >> 33772618

Impact of Bacillus licheniformis SV1 Derived Glycolipid on Candida glabrata Biofilm.

Sonam Gupta1,2, Payal Gupta3, Vikas Pruthi3.   

Abstract

In the present investigation, we have evaluated the antibiofilm potential of Bacillus licheniformis SV1 derived glycolipid against C. glabrata biofilm. Impact of isolated glycolipid on the viability of C. glabrata and on inhibiting as well as eradicating ability of its biofilm were studied. Further, morphological alterations, reactive oxygen species generation (ROS) production and transcriptional expression of selected genes (RT-PCR) of C. glabrata in response with isolated glycolipid were studied. The isolated glycolipid (1.0 mg ml-1) inhibited and eradicated C. glabrata biofilm approximately 80% and 60%, respectively. FE-SEM images revealed glycolipid exposure results in architectural alteration and eradication of C. glabrata biofilm and ROS generation. Transcriptional studies of selected genes showed that the expression of AUS1, FKS1 and KRE1 were down-regulated, while that of ergosterol biosynthesis pathway and multidrug transporter increased, in the presence of glycolipid.

Entities:  

Year:  2021        PMID: 33772618     DOI: 10.1007/s00284-021-02461-5

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  3 in total

1.  Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment.

Authors:  Mark Fraser; Andrew M Borman; Robin Thorn; Lynne M Lawrance
Journal:  Med Mycol       Date:  2019-05-21       Impact factor: 4.076

Review 2.  Recent advances on mycotic keratitis caused by dematiaceous hyphomycetes.

Authors:  Mahendra Rai; Avinash P Ingle; Pramod Ingle; Indarchand Gupta; Mitra Mobin; Alexandro Bonifaz; Monica Alves
Journal:  J Appl Microbiol       Date:  2021-01-19       Impact factor: 3.772

Review 3.  Forensic Applications of Microbiomics: A Review.

Authors:  Jake M Robinson; Zohar Pasternak; Christopher E Mason; Eran Elhaik
Journal:  Front Microbiol       Date:  2021-01-13       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.